Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir: Complete Statistical AnalysisIndependent statistical analysis of Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Changes of Pain and Functional Parameters in Back Pain Patients Over Time: Complete Statistical AnalysisIndependent statistical analysis of Changes of Pain and Functional Parameters in Back Pain Patients Over Time: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ChangHER-SCIndependent statistical analysis of Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Changing Lifestyles for Better Health: Complete Statistical AnalysisIndependent statistical analysis of Changing Lifestyles for Better Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00848757).
- Chantix for Treating Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Chantix for Treating Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00567008).
- Characteristics of Sleep Patterns in Young Adults With and Without Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Characteristics of Sleep Patterns in Young Adults With and Without Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CHARMSIndependent statistical analysis of Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D: Complete Statistical AnalysisIndependent statistical analysis of Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CheckMate 8HWIndependent statistical analysis of A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC):…
- CheckMate 914Independent statistical analysis of A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney: primary endpoint…
- Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease: Complete Statistical AnalysisIndependent statistical analysis of Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Chemoprevention of Gastric Carcinogenesis: Complete Statistical AnalysisIndependent statistical analysis of Chemoprevention of Gastric Carcinogenesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02794428).
- Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00176800).
- Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with…
- Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01102231).
- Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer: primary endpoint results, effect estimate…
- Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size…
- Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Chemotherapy for Patients With Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy for Patients With Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00380718).
- Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant: primary endpoint results,…
- CHLIndependent statistical analysis of Children's Healthy Living Community Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01881373).
- Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CHOICESIndependent statistical analysis of Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cholecalciferol and Flu Vaccine in Treating Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Cholecalciferol and Flu Vaccine in Treating Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01561989).
- Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501: Complete Statistical AnalysisIndependent statistical analysis of Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study: Complete Statistical AnalysisIndependent statistical analysis of Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China: Complete Statistical AnalysisIndependent statistical analysis of Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04853238).
- Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CHRONICLEIndependent statistical analysis of A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Chronotropic Incompetence in Patients With HFpEF: Complete Statistical AnalysisIndependent statistical analysis of Chronotropic Incompetence in Patients With HFpEF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02524145).
- Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM): Complete Statistical AnalysisIndependent statistical analysis of Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cigarette Pack Inserts for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Cigarette Pack Inserts for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04075682).
- Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor): Complete Statistical AnalysisIndependent statistical analysis of Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00093964).
- Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CiloMecTIndependent statistical analysis of Pharmacodynamic Study of Cilostazol in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02554721).
- Circadian Brown Adipose Tissue Metabolism: Complete Statistical AnalysisIndependent statistical analysis of Circadian Brown Adipose Tissue Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02285270).
- Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CIRTIndependent statistical analysis of Cardiovascular Inflammation Reduction Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01594333).
- Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Citicoline in Non-Arteritic Ischemic Optic Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Citicoline in Non-Arteritic Ischemic Optic Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03758118).
- Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…